Research
-
Guelcher, Wikswo are awardees in latest round of Vanderbilt’s Innovation Catalyst Fund
Two engineering professors are awardees in the latest round of Vanderbilt University’s Innovation Catalyst Fund, an initiative that supports translational research that has promising commercial potential. • Scott Guelcher, professor of chemical, biomolecular and biomedical engineering, for Preclinical Testing of Resorbable Surgical Mesh. • John Wikswo, University… Read MoreFeb. 17, 2025
-
Researchers simulate battlefield blast exposures to reduce impact on soldiers
By Craig Boerner Vanderbilt researchers are using BIHF — a Biofidelic Instrumented Head Form — to study the impact of blast exposures in the military, an idea that could translate to research in other areas, including contact sports such as football and hockey. Soldiers often come away from routine training… Read MoreFeb. 14, 2025
-
Vanderbilt researchers at forefront of global collaboration that advances preclinical imaging with diffusion MRI
Three seminal articles published in Magnetic Resonance in Medicine mark a landmark achievement in preclinical imaging science. These works, authored by an international consortium of 58 scientists, including Vanderbilt University’s Kurt Schilling, Bennett Landman, Adam Anderson, and Kevin Harkins, offer comprehensive guidelines for using diffusion magnetic resonance imaging (dMRI) in… Read MoreFeb. 3, 2025
-
Michael Miga named as Chair of Department of Biomedical Engineering
Michael Miga Following an extensive national search, Prof. Michael Miga has been named as the new chair of the Department of Biomedical Engineering, effective January 1, 2025. Miga, who had served as the interim chair since the Fall of 2023, and is the Harvie Branscomb Professor of Biomedical… Read MoreJan. 31, 2025
-
Ultrasound imaging of breast cancer tumors offers non-invasive monitoring of radiation and immunotherapy response effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreJan. 28, 2025
-
Turning challenges into breakthroughs: Vanderbilt team develops self-sealing for dialysis membranes using proteins
A Vanderbilt-led research team has made a significant breakthrough in developing advanced dialysis membranes using atomically thin materials like graphene. These innovative membranes, called nanoporous atomically thin membranes (NATMs), leverage a protein-enabled sealing mechanism to address a key challenge in dialysis technology, which is maintaining high efficiency in filtering… Read MoreJan. 24, 2025
-
Vanderbilt researchers lead successful clinical trial of advanced surgical robot to remove kidney stones
Surgeons at Vanderbilt University Medical Center (VUMC) have successfully completed the first-in-human clinical trial of a surgical robotic device developed by a Vanderbilt engineer to advance precision and control when removing kidney stones. The device is the first-known independently steerable kidney stone retrieval device, enabling more effective maneuvering… Read MoreDec. 3, 2024
-
Engineering professor De-en Jiang is among world’s highly cited researchers
De-en Jiang, professor of chemical and biomolecular engineering, and of chemistry, is on this year’s list of scientists whose papers have been cited the most frequently by other researchers. Jiang also was cited in the 2023 list. De-en Jiang He is among 6,636 “highly cited researchers” around the… Read MoreNov. 21, 2024
-
NSF grant to fund Vanderbilt-led research to develop world’s first custom GenAI 911 training system
Meiyi Ma, Assistant Professor of Computer Science Meiyi Ma, assistant professor of computer science at Vanderbilt, is leading research funded by a $300,000 National Science Foundation grant to develop what’s considered the world’s first Generative Artificial Intelligence (GenAI) training system for 911 call takers and dispatchers. The work… Read MoreNov. 20, 2024
-
In aggressive form of breast cancer, response to therapy may contribute to tumor regrowth, according to Vanderbilt-led study
A recent study by a team of researchers at Vanderbilt University found that response to radiation therapy for triple negative breast cancer (TNBC)—one of the most aggressive forms of the disease—may contribute to tumor recurrence. Marjan Rafat Marjan Rafat, assistant professor of chemical and biomolecular engineering, explained that radiation… Read MoreNov. 14, 2024